337 related articles for article (PubMed ID: 21103967)
21. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics.
Neuvonen PJ
Curr Opin Investig Drugs; 2010 Mar; 11(3):323-32. PubMed ID: 20178046
[TBL] [Abstract][Full Text] [Related]
22. Oral drug delivery utilizing intestinal OATP transporters.
Tamai I
Adv Drug Deliv Rev; 2012 May; 64(6):508-14. PubMed ID: 21824501
[TBL] [Abstract][Full Text] [Related]
23. Impact of OATP transporters on pharmacokinetics.
Kalliokoski A; Niemi M
Br J Pharmacol; 2009 Oct; 158(3):693-705. PubMed ID: 19785645
[TBL] [Abstract][Full Text] [Related]
24. Cellular entry of thyroid hormones by organic anion transporting polypeptides.
Hagenbuch B
Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):209-21. PubMed ID: 17574004
[TBL] [Abstract][Full Text] [Related]
25. Organic anion transporting polypeptides (OATP) in zebrafish (Danio rerio): Phylogenetic analysis and tissue distribution.
Popovic M; Zaja R; Smital T
Comp Biochem Physiol A Mol Integr Physiol; 2010 Mar; 155(3):327-35. PubMed ID: 19931635
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics of organic anion-transporting polypeptides (OATP).
Tirona RG; Kim RB
Adv Drug Deliv Rev; 2002 Nov; 54(10):1343-52. PubMed ID: 12406649
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.
Pizzagalli F; Hagenbuch B; Stieger B; Klenk U; Folkers G; Meier PJ
Mol Endocrinol; 2002 Oct; 16(10):2283-96. PubMed ID: 12351693
[TBL] [Abstract][Full Text] [Related]
28. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.
Roth M; Obaidat A; Hagenbuch B
Br J Pharmacol; 2012 Mar; 165(5):1260-87. PubMed ID: 22013971
[TBL] [Abstract][Full Text] [Related]
29. The role of organic anion transporting polypeptides (OATPs/SLCOs) in the toxicity of different microcystin congeners in vitro: a comparison of primary human hepatocytes and OATP-transfected HEK293 cells.
Fischer A; Hoeger SJ; Stemmer K; Feurstein DJ; Knobeloch D; Nussler A; Dietrich DR
Toxicol Appl Pharmacol; 2010 May; 245(1):9-20. PubMed ID: 20171238
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics of membrane transporters: a review of current approaches.
Sissung TM; Gardner ER; Gao R; Figg WD
Methods Mol Biol; 2008; 448():41-62. PubMed ID: 18370230
[TBL] [Abstract][Full Text] [Related]
31. Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides.
Dolton MJ; Roufogalis BD; McLachlan AJ
Clin Pharmacol Ther; 2012 Nov; 92(5):622-30. PubMed ID: 23033114
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.
Shitara Y; Sato H; Sugiyama Y
Annu Rev Pharmacol Toxicol; 2005; 45():689-723. PubMed ID: 15822193
[TBL] [Abstract][Full Text] [Related]
33. An evolutionarily ancient Oatp: insights into conserved functional domains of these proteins.
Cai SY; Wang W; Soroka CJ; Ballatori N; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G702-10. PubMed ID: 11897630
[TBL] [Abstract][Full Text] [Related]
34. Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE; Kim RB
Mol Pharm; 2009; 6(6):1644-61. PubMed ID: 19558188
[TBL] [Abstract][Full Text] [Related]
35. Organic anion-transporting polypeptides at the blood-brain and blood-cerebrospinal fluid barriers.
Westholm DE; Rumbley JN; Salo DR; Rich TP; Anderson GW
Curr Top Dev Biol; 2008; 80():135-70. PubMed ID: 17950374
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of human hepatic OATPs: functional consequences and effect on drug pharmacokinetics.
Nie Y; Yang J; Liu S; Sun R; Chen H; Long N; Jiang R; Gui C
Xenobiotica; 2020 Mar; 50(3):297-317. PubMed ID: 31180267
[TBL] [Abstract][Full Text] [Related]
37. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
38. Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake.
König J; Glaeser H; Keiser M; Mandery K; Klotz U; Fromm MF
Drug Metab Dispos; 2011 Jun; 39(6):1097-102. PubMed ID: 21430235
[TBL] [Abstract][Full Text] [Related]
39. Modification of OATP2B1-mediated transport by steroid hormones.
Grube M; Köck K; Karner S; Reuther S; Ritter CA; Jedlitschky G; Kroemer HK
Mol Pharmacol; 2006 Nov; 70(5):1735-41. PubMed ID: 16908597
[TBL] [Abstract][Full Text] [Related]
40. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.
Kobayashi D; Nozawa T; Imai K; Nezu J; Tsuji A; Tamai I
J Pharmacol Exp Ther; 2003 Aug; 306(2):703-8. PubMed ID: 12724351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
